The use of directional interstitial sources to improve dosimetry in breast brachytherapy
- University of Florida Proton Therapy Institute, Jacksonville, Florida 32206 (United States)
The purposes of this study were to investigate the feasibility of improving dosimetry with temporary low-dose-rate (LDR) multicatheter breast implants using directional {sup 125}I (iodine) interstitial sources and to provide a comparison of a patient treatment plan to that achieved by conventional high-dose-rate (HDR) interstitial breast brachytherapy. A novel {sup 125}I source emitting radiation in a specified direction has been developed. The directional sources contain an internal radiation shield that greatly reduces the intensity of radiation in the shielded direction. The sources have a similar dose distribution to conventional nondirectional sources on the unshielded side. The treatment plan for a patient treated with HDR interstitial brachytherapy with {sup 192}Ir (iridium) was compared with a directional {sup 125}I treatment plan using the same data set. Several dosimetric parameters are compared including target volume coverage, volume receiving 50%, 100%, and 150% of the prescription dose (V50, V100, and V150, respectively), dose homogeneity index (DHI), and the skin surface areas receiving 30%, 50%, and 80% of the prescription dose (S30, S50, and S80, respectively). The HDR and LDR prescription doses were 34 Gy in ten fractions delivered over five days and 45 Gy in 108 h, respectively. Similar and excellent target volume coverage was achieved by both directional LDR and HDR plans (99.2% and 97.5%, respectively). For a 170 cm{sup 3} target volume, the dosimetric parameters were similar for LDR and HDR: DHI was 0.82 in both cases, V100 was 214.4 cm{sup 3} and 225.7 cm{sup 3}, and V150 was 39.1 cm{sup 3} and 40.4 cm{sup 3}, respectively. However, with directional LDR, significant reductions in skin dose were achieved: S30 was reduced from 100.6 to 62.5 cm{sup 2}, S50 from 50.6 to 16.1 cm{sup 2}, and S80 from 2 cm{sup 2} to zero. The reduction in V50 for the whole breast was more than 100 cm{sup 3} (386.1 cm{sup 3} for LDR versus 489.2 cm{sup 3} for HDR). In this case study, compared with HDR, directional interstitial LDR {sup 125}I sources allow similar dose coverage to the subcutaneous target volume while lowering the skin dose due to a more conformal dose distribution and quicker falloff beyond the target. The improved dose distribution provided by directional interstitial brachytherapy might enable partial breast treatment to tumors closer to the skin or chest wall or in relatively small breasts.
- OSTI ID:
- 21036129
- Journal Information:
- Medical Physics, Journal Name: Medical Physics Journal Issue: 1 Vol. 35; ISSN 0094-2405; ISSN MPHYA6
- Country of Publication:
- United States
- Language:
- English
Similar Records
Accelerated partial breast irradiation: An analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy
High-Dose-Rate Prostate Brachytherapy Consistently Results in High Quality Dosimetry
Comparison of Dose Distributions With TG-43 and Collapsed Cone Convolution Algorithms Applied to Accelerated Partial Breast Irradiation Patient Plans
Journal Article
·
Tue Jan 31 23:00:00 EST 2006
· International Journal of Radiation Oncology, Biology and Physics
·
OSTI ID:20793309
High-Dose-Rate Prostate Brachytherapy Consistently Results in High Quality Dosimetry
Journal Article
·
Thu Jan 31 23:00:00 EST 2013
· International Journal of Radiation Oncology, Biology and Physics
·
OSTI ID:22149787
Comparison of Dose Distributions With TG-43 and Collapsed Cone Convolution Algorithms Applied to Accelerated Partial Breast Irradiation Patient Plans
Journal Article
·
Mon Aug 01 00:00:00 EDT 2016
· International Journal of Radiation Oncology, Biology and Physics
·
OSTI ID:22648772